This course has expired. View available courses.
Infectious Disease
Meningococcal Type B – Protecting Against the Most Common Cause of invasive meningococcal disease (IMD) in Canada
N. meningitidis serogroup B strain is the most prevalent form of invasive meningococcal disease in Canada. Although this infection is relatively rare, no other bacterial agent may kill as swiftly after bloodstream invasion as the meningococcus. With the availability of vaccines to protect against the different serogroups, it is important for clinicians to educate patients on the potential risks of meningococcal infection and the benefits of immunization. This program will review the clinical consequences of meningococcal type B infection, the different vaccine options and how it can be integrated into practice.
DURATION
1 Hour
PROFESSION
Physician
# OF CREDITS
1
ACCREDITATION
Mainpro+
EXPIRY DATE
2021-06-18
N. meningitidis serogroup B strain is the most prevalent form of invasive meningococcal disease in Canada. Although this infection is relatively rare, no other bacterial agent may kill as swiftly after bloodstream invasion as the meningococcus. With the availability of vaccines to protect against the different serogroups, it is important for clinicians to educate patients on the potential risks of meningococcal infection and the benefits of immunization. This program will review the clinical consequences of meningococcal type B infection, the different vaccine options and how it can be integrated into practice.
Faculty
Mark Awuku, MB, ChB, FRCP(C), FAAP, FGCP, LLD (Honoris Causa)
Dale Ziter, MD, CCFP, FCFP
Suni Boraston, MD, MHSC
Vivien Brown, MDCM, CCFP, FCFP, NCMP
Christine Palmay, CCFP, FCFP
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Describe meningococcal disease burden and prevention, addressing the importance of MenB protection for infants as early as two months of age, children, and adolescents, addressing disease epidemiology, disease significance & severity
- Review the challenges to MenB vaccine development, the indications and modes of action
- Highlight the growing body of scientific evidence supporting MenB vaccination e.g. real-world experience, dosing schedules, persistence data, immunogenicity data spanning the age cohorts at risk of disease
- Practical implications for non-publicly funded vaccines in the clinical practice: how to discuss MenB vaccination, where it can fit into the routine childhood vaccination schedule, and how to address questions/objections from parents
Accreditation
#
of credits: 1
Duration: 1 Hour
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
1 Hour
Duration
Physician
Profession
1
# of credits
Learning Objectives
Upon completion of this continuing education program, participants will be better able to:
- Describe meningococcal disease burden and prevention,
addressing the importance of MenB protection for infants as early as two months
of age, children, and adolescents, addressing disease epidemiology, disease
significance & severity - Review the challenges to MenB vaccine development, the
indications and modes of action - Highlight the growing body of
scientific evidence supporting MenB vaccination e.g. real-world experience,
dosing schedules, persistence data, immunogenicity data spanning the age
cohorts at risk of disease - Practical implications for non-publicly funded
vaccines in the clinical practice: how to discuss MenB vaccination, where it
can fit into the routine childhood vaccination schedule, and how to address
questions/objections from parents
Mainpro+
ACCREDITATION
Infectious Disease
Learning Category
General
Topic
0
Price
2021-06-18
Expiry Date
CAN-eng
Region/Language
Course Description
N. meningitidis serogroup B strain is the most prevalent form of invasive meningococcal disease in Canada. Although this infection is relatively rare, no other bacterial agent may kill as swiftly after bloodstream invasion as the meningococcus. With the availability of vaccines to protect against the different serogroups, it is important for clinicians to educate patients on the potential risks of meningococcal infection and the benefits of immunization. This program will review the clinical consequences of meningococcal type B infection, the different vaccine options and how it can be integrated into practice.
Faculty
Mark Awuku, MB, ChB, FRCP(C), FAAP, FGCP, LLD (Honoris Causa)
Dale Ziter, MD, CCFP, FCFP
Suni Boraston, MD, MHSC
Vivien Brown, MDCM, CCFP, FCFP, NCMP
Christine Palmay, CCFP, FCFP
Accreditation
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1 Mainpro+ credits.
1 Hour
Duration
0
Price
1
# of credits
